Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udo Jeschke

Showing results (251-260 of 401) with videos related to

Pageof 41
Sort By:
Virchows Archiv : an International Journal of Pathology|February 9, 2019
Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinomaElisa Schmoeckel, Sophie Hofmann, Daniel Fromberger, et al.
Journal of Reproductive Immunology|April 20, 2023
The programmed cell death protein 1 (PD1) and the programmed cell death ligand 1 (PD-L1) are significantly downregulated on macrophages and Hofbauer cells in the placenta of preeclampsia patientsJohanna Mittelberger, Marina Seefried, Sanja Löb, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 8, 2015
GDM Alters Expression of Placental Estrogen Receptor α in a Cell Type and Gender-Specific MannerJulia Knabl, Ursula Hiden, Rebecca Hüttenbrenner, et al.
Oncology Reports|February 12, 2005
Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrenceUdo Jeschke, Ioannis Mylonas, Christiane Kunert-Keil, et al.
Oncology Reports|December 5, 2006
Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markersSilvia Worbs, Naim Shabani, Doris Mayr, et al.
Anticancer Research|May 18, 2012
Determination of MUC1 in sera of ovarian cancer patients and in sera of patients with benign changes of the ovaries with CA15-3, CA27.29, and PankoMabUdo Jeschke, Irmi Wiest, Anamur Lan Schumacher, et al.
International Journal of Molecular Sciences|May 14, 2022
Regulatory T Cells with Additional COX-2 Expression Are Independent Negative Prognosticators for Vulvar Cancer PatientsNadine Ansorge, Christian Dannecker, Udo Jeschke, et al.
Histochemistry and Cell Biology|October 15, 2008
Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancerUdo Jeschke, Ioannis Mylonas, Christiane Kunert-Keil, et al.
Journal of Reproductive Immunology|May 25, 2020
Spliceosome protein EFTUD2 is upregulated in the trophoblast of spontaneous miscarriage and hydatidiform moleSanja Löb, Aurelia Vattai, Christina Kuhn, et al.
Molecular Medicine Reports|May 9, 2015
Glycosyltransferases as marker genes for the quantitative polymerase chain reaction-based detection of circulating tumour cells from blood samples of patients with breast cancer undergoing adjuvant therapyAlexandra C Kölbl, Roman A Hiller, Mathias Ilmer, et al.
Pageof 41

Showing results (251-260 of 401) with videos related to

Sort By:
Pageof 41
Virchows Archiv : an International Journal of Pathology|February 9, 2019
Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinomaElisa Schmoeckel, Sophie Hofmann, Daniel Fromberger, et al.
Journal of Reproductive Immunology|April 20, 2023
The programmed cell death protein 1 (PD1) and the programmed cell death ligand 1 (PD-L1) are significantly downregulated on macrophages and Hofbauer cells in the placenta of preeclampsia patientsJohanna Mittelberger, Marina Seefried, Sanja Löb, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 8, 2015
GDM Alters Expression of Placental Estrogen Receptor α in a Cell Type and Gender-Specific MannerJulia Knabl, Ursula Hiden, Rebecca Hüttenbrenner, et al.
Oncology Reports|February 12, 2005
Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrenceUdo Jeschke, Ioannis Mylonas, Christiane Kunert-Keil, et al.
Oncology Reports|December 5, 2006
Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markersSilvia Worbs, Naim Shabani, Doris Mayr, et al.
Anticancer Research|May 18, 2012
Determination of MUC1 in sera of ovarian cancer patients and in sera of patients with benign changes of the ovaries with CA15-3, CA27.29, and PankoMabUdo Jeschke, Irmi Wiest, Anamur Lan Schumacher, et al.
International Journal of Molecular Sciences|May 14, 2022
Regulatory T Cells with Additional COX-2 Expression Are Independent Negative Prognosticators for Vulvar Cancer PatientsNadine Ansorge, Christian Dannecker, Udo Jeschke, et al.
Histochemistry and Cell Biology|October 15, 2008
Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancerUdo Jeschke, Ioannis Mylonas, Christiane Kunert-Keil, et al.
Journal of Reproductive Immunology|May 25, 2020
Spliceosome protein EFTUD2 is upregulated in the trophoblast of spontaneous miscarriage and hydatidiform moleSanja Löb, Aurelia Vattai, Christina Kuhn, et al.
Molecular Medicine Reports|May 9, 2015
Glycosyltransferases as marker genes for the quantitative polymerase chain reaction-based detection of circulating tumour cells from blood samples of patients with breast cancer undergoing adjuvant therapyAlexandra C Kölbl, Roman A Hiller, Mathias Ilmer, et al.
Pageof 41